NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: AM Technology

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AM Technology Joins EU Funded Flow Chemistry Project - AM Technology are collaborating on an EU funded project to develop and scale up flow chemistry methods for the manufacture of pharmaceutical APIs
AM Technology Joins EU Funded Flow Chemistry Project

 

NewswireTODAY - /newswire/ - Runcorn, Cheshire, United Kingdom, 2009/09/13 - AM Technology are collaborating on an EU funded project to develop and scale up flow chemistry methods for the manufacture of pharmaceutical APIs.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AM Technology are pleased to announce their participation in a project to develop flow processes for industrial synthesis of pharmaceutical compounds. The ‘Pharmagen project’ is being coordinated by Serichim Srl and has other five partners; Flamma SA, Apotechnia SA, Carbopharm GbmH, PSE Ltd and LD&TI Sri. This work is being funded by the EU Commision DG Research within the VII Framework Program for Research and Development.

Global manufacturing costs, for pharmaceutical products in 2008 exceeded $200 billion. Greater use of flow chemistry within the industry will bring substantial benefits in terms of reduced manufacturing costs, lower carbon footprints and less pollution. Developing flow chemistry techniques for industrial pharmaceutical processes however faces a variety of technical and regulatory hurdles. The Pharmagen project will use a multi disciplinary approach for tackling these problems.

“Simultaneously controlling axial dispersion, mixing rate and reaction time in flow reactors can be very difficult, particularly where there is more than one phase” Said Robert Ashe of AM Technology. “This project brings together an outstanding combination of skills from manufacturing, simulation, engineering and chemistry. This approach will greatly accelerate the problem solving process in what is a complex area of process control”.

AM Technology (amtechuk.com) were selected as partners on this project for their experience and knowhow in reactor design. Based in Cheshire UK, they have extensive experience in the design and construction of both batch and continuous reactions. Their patented Coflore ACR (Agitated Cell Reactor) is the first truly modular multi stage CSTR and represents a breakthrough in flow reactor design. Dynamic mixers combined with multiple reaction stages, give the ACR outstanding mixing, plug flow and great versatility. The ACR is ideal for multi phase mixtures and its inherently low pressure drop characteristics simplify selection and calibration of the flow pumps.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AM Technology

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AM Technology Joins EU Funded Flow Chemistry Project

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
AM Technology |
Contact: Robert Ashe - AMTechUK.com 
+44(0)19 2823 7420 sales[.]amtechuk.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AM Technology securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AM Technology / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

BASF to Invest in its Aroma Ingredients Business by Expanding its Global Production Footprint eith New Plants in China and Germany
Otsuka Chemical and Yokogawa Electric to Launch SynCrest Inc., a Joint Venture Targeting the CRDMO Business for Middle-molecular Drugs
Ipsen, Université de Montréal and IRICoR Broaden Existing Oncology Partnership, with an Exclusive License Agreement & Two New Discovery-stage Programs
Flagship Biosciences Applauded by Frost & Sullivan for Changing Biomarker Analysis to Find Biomarkers that Aid Drug Development and Diagnostics
Cabometyx® in Combination with Nivolumab Shows Durable Survival Benefits At Over Three-years’ Follow-up in First-line Advanced Renal Cell Carcinoma
Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC
Ipsen Receives CHMP Negative Opinion for Palovarotene as A Treatment for Fibrodysplasia Ossificans Progressiva in E.U
Ipsen Presents Positive Results from the Pivotal Phase III NAPOLI 3 Trial Evaluating An Investigational Regimen of Onivyde®
SCHOTT Opens First Facility in U.S. to Increase Capabilities and Capacity for Development and Manufacturing of Diagnostics and Life Sciences Products
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
Ipsen Demonstrates Commitment to Innovation in Neuroscience At 12th World Congress for Neurorehabilitation (WCNR)
BASF Pharma Solutions Excipient Accepted into FDA Pilot Program for Novel Excipients
Digital Technologies Drive Growth Across the Biomanufacturing Value Chain Finds Frost & Sullivan
DSM Starts Construction of Large Scale Production Facility for its Novel Methane-reducing Feed Additive for Ruminants, Bovaer® in Dalry, Scotland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2023 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)